Pure Global

"Stryker" Target split coil - Taiwan Registration 79cb8c5daaeae76d1b3609d55a40c36c

Access comprehensive regulatory information for "Stryker" Target split coil in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number 79cb8c5daaeae76d1b3609d55a40c36c and manufactured by Stryker Neurovascular. The authorized representative in Taiwan is STRYKER FAR EAST INC. TAIWAN BRANCH (USA).

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
79cb8c5daaeae76d1b3609d55a40c36c
Registration Details
Taiwan FDA Registration: 79cb8c5daaeae76d1b3609d55a40c36c
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

"Stryker" Target split coil
TW: โ€œๅฒ่ณฝๅ…‹โ€ๅก”ๅ‰็‰นๅˆ†้›ข็ทšๅœˆ
Risk Class 3

Registration Details

79cb8c5daaeae76d1b3609d55a40c36c

DHA00602237703

Company Information

Ireland

Product Details

For details, it is Chinese approved copy of the imitation order

K Neuroscience

K.5950 Artificial embolization device

import

Dates and Status

May 09, 2011

May 09, 2026